Ciaglia, Elena <br/><br/>
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells.  [electronic resource] 

 -  Oncotarget  Jun 2015 
 - 15464-81 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.3895  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Astrocytes--metabolism<br/>Brain Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>G1 Phase Cell Cycle Checkpoints--drug effects<br/>Glioma--drug therapy<br/>Histocompatibility Antigens Class I--biosynthesis<br/>Humans<br/>Killer Cells, Natural--immunology<br/>Mice<br/>Mice, Nude<br/>Piperidines--pharmacology<br/>Pyrazoles--pharmacology<br/>RNA Interference<br/>RNA, Small Interfering<br/>Receptor, Cannabinoid, CB1--antagonists & inhibitors<br/>Rimonabant<br/>STAT3 Transcription Factor--antagonists & inhibitors<br/>Transforming Growth Factor beta1--metabolism<br/>Xenograft Model Antitumor Assays